4.1 Review

Urobiome: An outlook on the metagenome of urological diseases

期刊

INVESTIGATIVE AND CLINICAL UROLOGY
卷 62, 期 6, 页码 611-622

出版社

KOREAN UROLOGICAL ASSOC
DOI: 10.4111/icu.20210312

关键词

Microbiome; Mycobiome; Urology

资金

  1. National Institutes of Health [1U01DK103260, 1R01DK100974, U24 DK097154]
  2. National Institutes of Health (NIH NCATS UCLA CTSI) [UL1TR000124]
  3. Department of Defense [W81XWH-15-1-0415, W81XWH-19-1-0109]
  4. Centers for Disease Control and Prevention [1U01DP006079]
  5. U.S.Egypt Science and Technology Development Fund by the National Academies of Sciences, Engineering, and Medicine
  6. National Academies of Sciences, Engineering, and Medicine (NAS)
  7. United States Agency for International Development (USAID)
  8. Samuel Oschin Comprehensive Cancer Institute (SOCCI) at Cedars-Sinai Medical Center

向作者/读者索取更多资源

Recent studies have shown that the urinary tract hosts a complex microbiome, which is associated with urinary diseases, but whether the changes are causative or correlative remains uncertain. Further research on healthy vs. diseased microbiomes, the effects of antibiotic treatments, and the urinary mycobiome will be crucial in understanding the relationship between the urinary microbiome and human health.
The urinary tract likely plays a role in the development of various urinary diseases due to the recently recognized notion that urine is not sterile. In this mini review, we summarize the current literature regarding the urinary microbiome and mycobiome and its relationship to various urinary diseases. It has been recently discovered that the healthy urinary tract contains a host of micro-organisms, creating a urinary microbiome. The relative abundance and type of bacteria varies, but generally, deviations in the standard microbiome are observed in individuals with urologic diseases, such as bladder cancer, benign prostatic hyperplasia, urgency urinary incontinence, overactive bladder syndrome, interstitial cystitis, bladder pain syndrome, and urinary tract infections. However, whether this change is causative, or correlative has yet to be determined. In summary, the urinary tract hosts a complex microbiome. Changes in this microbiome may be indicative of urologic diseases and can be tracked to predict, prevent, and treat them in individuals. However, current analytical and sampling collection methods may present limitations to the development in the understanding of the urinary microbiome and its relationship with various urinary diseases. Further research on the differences between healthy and diseased microbiomes, the long-term effects of antibiotic treatments on the urobiome, and the effect of the urinary mycobiome on general health will be important in developing a comprehensive understanding of the urinary microbiome and its relationship to the human body.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据